Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
43 /100
MEDIUM RISK
Score updated Aug 28, 2026

BIOA — BioAge Labs, Inc. Dilution Risk Tracker

Track BIOA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BIOA — Get alerts when the score changes →

As of August 28, 2026, BioAge Labs, Inc. (BIOA) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. BioAge Labs, Inc. has a market capitalization of $768.59M, 45.90M shares outstanding, 146 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $115.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
62
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise model 18%
• Active ATM program with $115M remaining capacity
🔔 Track BIOA — Get forecast alerts →

Market Data

Market Cap$768.59M
Shares Outstanding45.90M
Float33.69M
Cash$318.75M
Debt$1.16M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 64.6% shares (2026Q1 vs prior)
146 institutional holders · 39.24M shares
#1 JANUS HENDERSON GROUP PLC 4.19M shares
#2 a16z Capital Management, L.L.C. 3.23M shares
#3 Cormorant Asset Management, LP 2.89M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.57M
Days to Cover1.9
% of Float7.6%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31
xbrl XBRL WARRANT 2025-12-31
4 INSIDER TRANSACTION 2026-04-03
4 INSIDER TRANSACTION 2026-03-03
4 INSIDER TRANSACTION 2026-03-03
Full SEC filing analysis available with free account

Recent News

No recent news

Factual BIOA Dilution Snapshot

BioAge Labs, Inc. (BIOA) has a DilutionScore of 43/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track BIOA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BIOA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BIOA
BIOA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.